Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
Anticancer agent 84
Item number: TGM-T74961-50mg
Description: Anticancer Agent 84, a cancer research compound, inhibits c-MYC transcription by stabilizing the G-quadruplex (G4) structure, offering potential for cancer investigation [1]. Target: Others
| CAS | 2714510-72-0 |
| MW: | 994.18 D |
Please request pricing for this article.
GLUT1-IN-1
Item number: TGM-T74962-50mg
Description: GLUT1-IN-1, a glucose transporter 1 (GLUT1) inhibitor, possesses specific inactivation capability for GLUT1. This compound demonstrates concentration-dependent cytotoxicity towards HeLa, A549, and HepG2 cells, with IC50 values of 5.49 µM, 11.14 µM, and 8.73 µM, respectively. It is utilized in the...
| MW: | 830.17 D |
Please request pricing for this article.
CypD-IN-3
Item number: TGM-T74963-50mg
Description: CypD-IN-3, a potent and subtype-selective cyclophilin D (CypD) inhibitor, exhibits a high affinity for CypD with an IC50 value of 0.01 µM. It is applicable in the research of various conditions, such as oxidative stress, neurodegenerative disorders, liver diseases, aging, autophagy, and diabetes [1]....
| CAS | 2651994-75-9 |
| MW: | 972.09 D |
Please request pricing for this article.
CypD-IN-4
Item number: TGM-T74964-50mg
Description: CypD-IN-4 is a potent, subtype-selective cyclophilin D (CypD) inhibitor exhibiting a high affinity for CypD with an IC50 value of 0.057 µM. This compound is utilized in the research of various diseases, such as oxidative stress, neurodegenerative disorders, liver diseases, aging, autophagy, and diabetes...
| MW: | 986.12 D |
Please request pricing for this article.
CypE-IN-1
Item number: TGM-T74965-50mg
Description: CypD-IN-1, a potent and subtype-selective inhibitor targeting cyclophilin E (CypE), demonstrates high affinity with IC50 and Ki values of 0.013 µM and 0.072 µM, respectively. This compound is valuable for research into various conditions, including oxidative stress, neurodegenerative disorders, liver...
| MW: | 840.73 D |
Please request pricing for this article.
Antimicrobial agent-10
Item number: TGM-T74966-50mg
Description: Antimicrobial Agent-10 demonstrates exceptional antibacterial activity and inhibits SARS-CoV-2, positioning it as a potent antimicrobial compound [1]. Target: Others
| MW: | 1844.29 D |
Please request pricing for this article.
Antimicrobial agent-11
Item number: TGM-T74967-50mg
Description: Antimicrobial agent-11 is a SARS-CoV-2 inhibitor with antibacterial activity [1]. Target: Others
| MW: | 1876.23 D |
Please request pricing for this article.
Antimicrobial agent-12
Item number: TGM-T74968-50mg
Description: Antimicrobial agent-12 serves as a powerful antibacterial compound that also exhibits inhibitory activity against SARS-CoV-2 [1]. Target: Others
| MW: | 1558.18 D |
Please request pricing for this article.
Phospholipid PL1
Item number: TGM-T74969-1mg
Description: Phospholipid PL1, a phospholipid-derived nanoparticle, efficiently delivers costimulatory receptor mRNA (CD137 or OX40) to T cells, thereby inducing the activation of immune cells such as T cells and dendritic cells (DCs) to enhance antitumor immunity [1]. Target: Others
| CAS | 2274812-94-9 |
| MW: | 1073.59 D |
From 271.00€
*
306Oi10
Item number: TGM-T74970-2mg
Description: 306Oi10, a branched-chain ionizable lipidoid, facilitates the construction of lipid nanoparticles (LNPs) for messenger RNA delivery [1]. Target: Others
| CAS | 2322290-93-5 |
| MW: | 994.56 D |
101.00€
*
KRas G12R inhibitor 1
Item number: TGM-T74973-50mg
Description: KRas G12R Inhibitor 1 (compound 3) is a selective covalent inhibitor targeting the KRas G12R mutation, leveraging the high nucleophilicity of mutant cysteines to bind irreversibly within the K-Ras Switch II region. This compound is utilized in cancer research [1]. Target: Others
| MW: | 903.2 D |
Please request pricing for this article.
SQ-3
Item number: TGM-T74974-50mg
Description: SQ-3, a quinoline analogue, demonstrates moderate selectivity towards alpha-synuclein aggregates (alpha-syn aggregates) (K i = 39.3 nM) over beta-amyloid (Abeta) aggregates (K i = 230 nM). [18 F]SQ-3 exhibits foundational characteristics as a potential lead compound in developing an effective...
| MW: | 336.4 D |
Please request pricing for this article.